Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate DBV Technologies S.A. before investing.

In this article, we go over a few key elements for understanding DBV Technologies S.A.’s stock price such as:

• DBV Technologies S.A.’s current stock price and volume
• Why DBV Technologies S.A.’s stock price changed recently
• Upgrades and downgrades for DBVT from analysts
• DBVT’s stock price momentum as measured by its relative strength

About DBV Technologies S.A. (DBVT)

Before we jump into DBV Technologies S.A.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Want to learn more about DBV Technologies S.A.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about DBV Technologies S.A..

DBV Technologies S.A.’s Stock Price as of Market Close

As of April 14, 2026, 9:45 AM, CST, DBV Technologies S.A.’s stock price was $22.790.

DBV Technologies S.A. is up 2.94% from its previous closing price of $22.140.

During the last market session, DBV Technologies S.A.’s stock traded between $22.640 and $23.040. Currently, there are approximately 184.13 million shares outstanding for DBV Technologies S.A..

DBV Technologies S.A.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

DBV Technologies S.A. Stock Price History

DBV Technologies S.A.’s (DBVT) price is currently up 9.1% so far this month.

During the month of April, DBV Technologies S.A.’s stock price has reached a high of $23.040 and a low of $19.770.

Over the last year, DBV Technologies S.A. has hit prices as high as $26.185 and as low as $7.000. Year to date, DBV Technologies S.A.’s stock is up 18.88%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused DBV Technologies S.A. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 13, 2026, there were 0 analysts who downgraded DBV Technologies S.A.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate DBV Technologies S.A.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on DBV Technologies S.A.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

DBV Technologies S.A.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about DBV Technologies S.A. (DBVT) by visiting AAII Stock Evaluator.

Relative Price Strength of DBV Technologies S.A.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 13, 2026, DBV Technologies S.A. has a weighted four-quarter relative price strength of 24.43%, which translates to a Momentum Score of 91 and is considered to be Very Strong.

Want to learn more about how DBV Technologies S.A. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

DBV Technologies S.A. Stock Price: Bottom Line

As of April 14, 2026, DBV Technologies S.A.’s stock price is $22.790, which is up 2.94% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like DBV Technologies S.A. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.